29.02USD-2.09%Mkt Cap: 2.55B USDP/E: —Last update: 2026-06-01
IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company offers Darovasertib, an oral,…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap2.55B USD
Enterprise Value1.95B USD
Revenue (TTM)225.27M USD
Gross Profit-114.27M USD
Net Income (TTM)-113.70M USD
Revenue/Share2.543 USD
Last Price29.02 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees145
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45166A1025
Valuation
P/E (Trailing)—
P/E (Forward)-7.90
PEG—
EV/EBITDA-10.77
EV/Revenue8.64
P/S11.49
P/B2.53
EPS (TTM)-1.57
EPS (Forward)-3.73
52W Range
19.4848% of range39.28
52W High39.28 USD
52W Low19.48 USD
Profitability
Gross Margin-50.73%
Oper. Margin-1654.63%
EBITDA Margin-80.21%
Profit Margin-51.99%
ROE-11.11%
ROA-10.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-71.10M USD
CapEx (TTM)2.37M USD
FCF Margin-25.42%
FCF Yield-2.25%
Net Debt-642.60M USD
Net Debt/EBITDA3.56
Balance Sheet
Debt/Equity0.03
Current Ratio10.74
Quick Ratio10.45
Book Value/Sh11.65 USD
Cash/Share7.639 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)51.69 USD
Target Range36.00 USD – 66.00 USD
# Analysts16
Ownership
Shares Out.87.86M
Float87.01M
Insiders2.41%
Institutions110.01%
Short Interest
Short Ratio11.6d
Short % Float15.72%
Short % Out.13.32%
Shares Short11.70M
Short (prev mo.)10.56M
Technical
SMA 5030.49 (-4.8%)
SMA 20030.86 (-6.0%)
Beta-0.04
S&P 52W Chg27.94%
Avg Vol (30d)789.30K
Avg Vol (10d)690.23K
Technical Indicators
RSI (14)51.6
MACD-0.2903
MACD Signal-0.5211
MACD Hist.+0.2308
BB Upper29.83 USD
BB Middle28.78 USD
BB Lower27.73 USD
BB Width7.29%
ATR (14)1.175 USD
Vol Ratio (20d)0.56x